Abstract Background Radiotherapy (RT) is a key treatment modality in cancer therapy, utilizing high‐energy radiation to directly kill tumor cells. Recent research has increasingly highlighted RT's potential to indirectly enhance antitumor immunity. However, this immune activation alone often fails to generate sustained systemic antitumor responses.
Xuejiao Han+11 more
wiley +1 more source
Faecalibacterium prausnitzii promotes anti-PD-L1 efficacy in natural killer/T-cell lymphoma by enhancing antitumor immunity. [PDF]
Shi Z+7 more
europepmc +1 more source
Clinical Images: Subcutaneous panniculitis‐like T cell lymphoma
Arthritis &Rheumatology, EarlyView.
S Chambers, CN Myrdal, VP Werth
wiley +1 more source
Combating cancer immunotherapy resistance: a nano‐medicine perspective
Abstract Cancer immunotherapy offers renewed hope for treating this disease. However, cancer cells possess inherent mechanisms that enable them to circumvent each stage of the immune cycle, thereby evading anti‐cancer immunity and leading to resistance.
Xiangyi Kong+10 more
wiley +1 more source
Presentation of extranodal NK/T-cell lymphoma as a pituitary mass: A case report and review of the literature. [PDF]
Butler M+10 more
europepmc +1 more source
Neutrophils in cancer: At the crucial crossroads of anti‐tumor and pro‐tumor
Abstract Neutrophils are important components of the immune system and play a key role in defending against pathogenic infections and responding to inflammatory cues, including cancer. Their dysregulation indicates potential disease risk factors. However, their functional importance in disease progression has often been underestimated due to their ...
Wenpeng Cai+6 more
wiley +1 more source
A Rare Presentation of a Devastating Disease: Hepatosplenic T-Cell Lymphoma in Crohn's Disease Without Thiopurine Exposure. [PDF]
Chang M+3 more
europepmc +1 more source
Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma of the Duodenum. [PDF]
Babbar S, Cerezo J, Williams R.
europepmc +1 more source
Abstract Background Diffuse large B‐cell lymphoma (DLBCL) is the most common subtype of aggressive non‐Hodgkin's lymphoma with distinct clinical and molecular heterogeneity. DLBCL that arises in extranodal organs is particularly linked to poor prognosis. This study aimed to determine the clinical and molecular characteristics of extranodal involvement (
Si‐Yuan Chen+46 more
wiley +1 more source
CD38 in the pathobiology of cutaneous T-cell lymphoma and the potential for combination therapeutic intervention. [PDF]
Isabelle C+12 more
europepmc +1 more source